ELEVANCE HEALTH, INC. Available-for-sale Securities, Gross Realized Losses
ELEVANCE HEALTH, INC. (ELV) reported Available-for-sale Securities, Gross Realized Losses of $14.00 million for the 3-month period ending 2020-09-30, per its 10-Q filed 2020-10-28.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossRealizedLosses · last filed 2020-10-28
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized losses for the quarter ending 2020-09-30 was $14.00M, a 55.56% increase year-over-year.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized losses for the quarter ending 2020-06-30 was $50.00M, a 194.12% increase year-over-year.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized losses for the quarter ending 2020-03-31 was $20.00M, a 17.65% increase year-over-year.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized losses for the quarter ending 2019-09-30 was $9.00M, a 43.75% decline year-over-year.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized losses for fiscal 2017 was $76.70M, a 62.12% decline from fiscal 2016.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized losses for fiscal 2016 was $202.50M, a 10.87% decline from fiscal 2015.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized losses for fiscal 2015 was $227.20M, a 252.25% increase from fiscal 2014.
- ELEVANCE HEALTH, INC. available-for-sale securities, gross realized losses for fiscal 2014 was $64.50M, a 74.28% decline from fiscal 2013.
| Period end | Available-for-sale Securities, Gross Realized Losses 3 month | Available-for-sale Securities, Gross Realized Losses 3 month as first filed | Available-for-sale Securities, Gross Realized Losses 6 month | Available-for-sale Securities, Gross Realized Losses 6 month as first filed | Available-for-sale Securities, Gross Realized Losses 9 month | Available-for-sale Securities, Gross Realized Losses 9 month as first filed | Available-for-sale Securities, Gross Realized Losses 12 month | Available-for-sale Securities, Gross Realized Losses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-09-30 | $14.00M 10-Q · filed 2020-10-28 | $64.00M derived: sum of 2 quarters · filed 2020-10-28 | $84.00M 10-Q · filed 2020-10-28 | |||||
| 2020-06-30 | $50.00M 10-Q · filed 2020-07-29 | $70.00M 10-Q · filed 2020-07-29 | ||||||
| 2020-03-31 | $20.00M 10-Q · filed 2020-04-29 | |||||||
| 2019-09-30 | $9.00M 10-Q · filed 2020-10-28 | $26.00M derived: sum of 2 quarters · filed 2020-10-28 | $43.00M 10-Q · filed 2020-10-28 | |||||
| 2019-06-30 | $17.00M 10-Q · filed 2020-07-29 | $34.00M 10-Q · filed 2020-07-29 | ||||||
| 2019-03-31 | $17.00M 10-Q · filed 2020-04-29 | |||||||
| 2018-09-30 | $16.00M 10-Q · filed 2019-10-23 | $48.60M derived: sum of 2 quarters · filed 2019-10-23 | $85.00M 10-Q · filed 2019-10-23 | $109.30M derived: sum of 4 quarters · filed 2019-10-23 | ||||
| 2018-06-30 | $32.60M 10-Q · filed 2018-07-25 | $69.00M 10-Q · filed 2019-07-24 | $93.30M derived: sum of 3 quarters · filed 2019-07-24 | $102.30M derived: sum of 4 quarters · filed 2019-07-24 | ||||
| 2018-03-31 | $33.00M 10-Q · filed 2019-07-24 | $36.40M 10-Q · filed 2018-04-25 | $60.70M derived: sum of 2 quarters · filed 2019-07-24 | $69.70M derived: sum of 3 quarters · filed 2019-07-24 | $86.30M derived: sum of 4 quarters · filed 2019-07-24 | |||
| 2017-12-31 | $27.70M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $36.70M derived: sum of 2 quarters · filed 2018-10-31 | $53.30M derived: sum of 3 quarters · filed 2018-10-31 | $76.70M 10-K · filed 2018-02-21 | ||||
| 2017-09-30 | $9.00M 10-Q · filed 2018-10-31 | $17.20M 10-Q · filed 2017-10-25 | $25.60M derived: sum of 2 quarters · filed 2018-10-31 | $49.00M 10-Q · filed 2018-10-31 | $67.50M 10-Q · filed 2017-10-25 | $115.10M derived: sum of 4 quarters · filed 2018-10-31 | ||
| 2017-06-30 | $16.60M 10-Q · filed 2018-07-25 | $20.10M 10-Q · filed 2017-07-26 | $40.30M 10-Q · filed 2018-07-25 | $50.30M 10-Q · filed 2017-07-26 | $106.10M derived: sum of 3 quarters · filed 2018-07-25 | $119.10M derived: sum of 4 quarters · filed 2018-07-25 | ||
| 2017-03-31 | $23.70M 10-Q · filed 2018-04-25 | $30.20M 10-Q · filed 2017-04-26 | $89.50M derived: sum of 2 quarters · filed 2018-04-25 | $102.50M derived: sum of 3 quarters · filed 2018-04-25 | $133.50M derived: sum of 4 quarters · filed 2018-04-25 | |||
| 2016-12-31 | $65.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $78.80M derived: sum of 2 quarters · filed 2018-02-21 | $109.80M derived: sum of 3 quarters · filed 2018-02-21 | $202.50M 10-K · filed 2018-02-21 | ||||
| 2016-09-30 | $13.00M 10-Q · filed 2017-10-25 | $44.00M derived: sum of 2 quarters · filed 2017-10-25 | $136.70M 10-Q · filed 2017-10-25 | $159.20M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | $31.00M 10-Q · filed 2017-07-26 | $123.70M 10-Q · filed 2017-07-26 | $146.20M derived: sum of 3 quarters · filed 2018-02-21 | $207.60M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-03-31 | $92.70M 10-Q · filed 2017-04-26 | $115.20M derived: sum of 2 quarters · filed 2018-02-21 | $176.60M derived: sum of 3 quarters · filed 2018-02-21 | $232.70M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2015-12-31 | $22.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $83.90M derived: sum of 2 quarters · filed 2018-02-21 | $140.00M derived: sum of 3 quarters · filed 2018-02-21 | $227.20M 10-K · filed 2018-02-21 | $351.60M 10-K · filed 2016-02-19 | |||
| 2015-09-30 | $61.40M 10-Q · filed 2016-11-02 | -$61.40M 10-Q · filed 2015-10-28 | $117.50M derived: sum of 2 quarters · filed 2016-11-02 | $204.70M 10-Q · filed 2016-11-02 | -$204.70M 10-Q · filed 2015-10-28 | $357.50M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2015-06-30 | $56.10M 10-Q · filed 2016-07-27 | -$56.10M 10-Q · filed 2015-07-29 | $143.30M 10-Q · filed 2016-07-27 | -$143.30M 10-Q · filed 2015-07-29 | $296.10M derived: sum of 3 quarters · filed 2017-02-22 | $289.40M derived: sum of 4 quarters · filed 2017-02-22 | ||
| 2015-03-31 | $87.20M 10-Q · filed 2016-04-27 | -$87.20M 10-Q · filed 2015-04-29 | $240.00M derived: sum of 2 quarters · filed 2017-02-22 | $233.30M derived: sum of 3 quarters · filed 2017-02-22 | $192.90M derived: sum of 4 quarters · filed 2017-02-22 | |||
| 2014-12-31 | $152.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | $146.10M derived: sum of 2 quarters · filed 2017-02-22 | $105.70M derived: sum of 3 quarters · filed 2017-02-22 | $64.50M 10-K · filed 2017-02-22 | $140.80M 10-K · filed 2015-02-24 | |||
| 2014-09-30 | -$6.70M 10-Q · filed 2015-10-28 | -$47.10M derived: sum of 2 quarters · filed 2015-10-28 | -$88.30M 10-Q · filed 2015-10-28 | $351.00M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | -$40.40M 10-Q · filed 2015-07-29 | -$81.60M 10-Q · filed 2015-07-29 | $357.70M derived: sum of 3 quarters · filed 2016-02-19 | $277.10M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | -$41.20M 10-Q · filed 2015-04-29 | $41.20M 10-Q · filed 2014-04-30 | $398.10M derived: sum of 2 quarters · filed 2016-02-19 | $317.50M derived: sum of 3 quarters · filed 2016-02-19 | $299.80M derived: sum of 4 quarters · filed 2016-02-19 | |||
| 2013-12-31 | $439.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $358.70M derived: sum of 2 quarters · filed 2016-02-19 | $341.00M derived: sum of 3 quarters · filed 2016-02-19 | $250.80M 10-K · filed 2016-02-19 | $226.20M 10-K · filed 2014-02-20 | |||
| 2013-09-30 | -$80.60M 10-Q · filed 2014-10-29 | $65.00M 10-Q · filed 2013-10-23 | -$98.30M derived: sum of 2 quarters · filed 2014-10-29 | -$188.50M 10-Q · filed 2014-10-29 | $172.90M 10-Q · filed 2013-10-23 | $8.40M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | -$17.70M 10-Q · filed 2014-07-30 | -$107.90M 10-Q · filed 2013-07-24 | $89.00M derived: sum of 3 quarters · filed 2015-02-24 | $143.40M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | $90.20M 10-Q · filed 2014-04-30 | $106.70M derived: sum of 2 quarters · filed 2015-02-24 | $161.10M derived: sum of 3 quarters · filed 2015-02-24 | $132.70M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | $16.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $70.90M derived: sum of 2 quarters · filed 2015-02-24 | $42.50M derived: sum of 3 quarters · filed 2015-02-24 | $148.60M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | $54.40M 10-Q · filed 2013-10-23 | $26.00M derived: sum of 2 quarters · filed 2013-10-23 | $132.10M 10-Q · filed 2013-10-23 | $160.90M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2012-06-30 | -$28.40M 10-Q · filed 2013-07-24 | -$77.70M 10-Q · filed 2013-07-24 | $77.70M 10-Q · filed 2012-07-25 | $106.50M derived: sum of 3 quarters · filed 2014-02-20 | $96.90M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2012-03-31 | $49.30M 10-Q · filed 2012-04-25 | $134.90M derived: sum of 2 quarters · filed 2014-02-20 | $125.30M derived: sum of 3 quarters · filed 2014-02-20 | $142.30M derived: sum of 4 quarters · filed 2014-02-20 | ||||
| 2011-12-31 | $85.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | $76.00M derived: sum of 2 quarters · filed 2014-02-20 | $93.00M derived: sum of 3 quarters · filed 2014-02-20 | $133.10M 10-K · filed 2014-02-20 | ||||
| 2011-09-30 | -$9.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-26 | $7.40M derived: sum of 2 quarters · filed 2011-10-26 | $47.50M 10-Q · filed 2011-10-26 | $95.60M derived: sum of 4 quarters · filed 2011-10-26 | ||||
| 2011-06-30 | $17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-27 | $57.10M 10-Q · filed 2011-07-27 | $105.20M derived: sum of 3 quarters · filed 2011-07-27 | $230.00M derived: sum of 4 quarters · filed 2011-07-27 | ||||
| 2011-03-31 | $40.10M 10-Q · filed 2011-04-27 | $88.20M derived: sum of 2 quarters · filed 2011-04-27 | $213.00M derived: sum of 3 quarters · filed 2011-04-27 | |||||
| 2010-12-31 | $48.10M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-17 | $172.90M derived: sum of 2 quarters · filed 2011-02-17 | $120.50M 10-K · filed 2011-02-17 | |||||
| 2010-09-30 | $124.80M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2010-11-03 | $72.40M 10-Q · filed 2010-11-03 | ||||||
| 2010-06-30 | -$52.40M 10-Q/A · filed 2010-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |